Terms: = Breast cancer AND TCF3, E2A, 6929, ENSG00000071564, P15923, MGC129648, MGC129647, ITF1
31 results:
1. Major regulators of the multi-step metastatic process are potential therapeutic targets for breast cancer management.
de Azevedo ALK; Carvalho TM; Mara CS; Giner IS; de Oliveira JC; Gradia DF; Cavalli IJ; Ribeiro EMSF
Funct Integr Genomics; 2023 May; 23(2):171. PubMed ID: 37211553
[TBL] [Abstract] [Full Text] [Related]
2. CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling.
Chen ZH; Tian Y; Zhou GL; Yue HR; Zhou XJ; Ma HY; Ge J; Wang X; Cao XC; Yu Y
Breast Cancer Res; 2023 Feb; 25(1):22. PubMed ID: 36829181
[TBL] [Abstract] [Full Text] [Related]
3. The miR526b-5p-Related Single Nucleotide Polymorphisms, rs72618599, Located in 3'-UTR of tcf3 Gene, is Associated with the Risk of breast and Gastric cancers.
Mohammadi M; Salehzadeh A; Talesh Sasani S; Tarang A
Iran Biomed J; 2022 Jan; 26(1):53-63. PubMed ID: 34700372
[TBL] [Abstract] [Full Text] [Related]
4. e2a Modulates Stemness, Metastasis, and Therapeutic Resistance of breast cancer.
López-Menéndez C; Vázquez-Naharro A; Santos V; Dubus P; Santamaría PG; Martínez-Ramírez Á; Portillo F; Moreno-Bueno G; Faraldo MM; Cano A
Cancer Res; 2021 Sep; 81(17):4529-4544. PubMed ID: 34145034
[TBL] [Abstract] [Full Text] [Related]
5. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
Hata T; Nakamura K; Yonemori K; Noguchi E; Watanabe M; Sohn J; Lu YS; Yap YS; Tamura K; Fujiwara Y
Clin Transl Sci; 2021 May; 14(3):1015-1025. PubMed ID: 33382914
[TBL] [Abstract] [Full Text] [Related]
6. tcf3-activated FAM201A enhances cell proliferation and invasion via miR-186-5p/TNKS1BP1 axis in triple-negative breast cancer.
Jia H; Wu D; Zhang Z; Li S
Bioorg Chem; 2020 Nov; 104():104301. PubMed ID: 33011533
[TBL] [Abstract] [Full Text] [Related]
7. RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.
Wada M; Goto Y; Tanaka T; Okada R; Moriya S; Idichi T; Noda M; Sasaki K; Kita Y; Kurahara H; Maemura K; Natsugoe S; Seki N
J Hum Genet; 2020 Nov; 65(11):1019-1034. PubMed ID: 32623445
[TBL] [Abstract] [Full Text] [Related]
8. [Epidemidogical Analysis of 982 Hospitalized Cases of Childhood Acute Lymphoblastic Leukemia].
Cai YL; Zou Y; Chen XJ; Zhang L; Guo Y; Yang WY; Chen YM; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):371-376. PubMed ID: 32319365
[TBL] [Abstract] [Full Text] [Related]
9. A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients.
Zheng T; Pang Z; Zhao Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988073
[TBL] [Abstract] [Full Text] [Related]
10. miR205 inhibits stem cell renewal in SUM159PT breast cancer cells.
Mayoral-Varo V; Calcabrini A; Sánchez-Bailón MP; Martín-Pérez J
PLoS One; 2017; 12(11):e0188637. PubMed ID: 29182685
[TBL] [Abstract] [Full Text] [Related]
11. RNAi-mediated
Ma J; Wang XB; Li R; Xuan SH; Wang F; Li XH; Zhang ZP; Tan L; Li L
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28864779
[TBL] [Abstract] [Full Text] [Related]
12. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract] [Full Text] [Related]
13. LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway.
Cuevas EP; Eraso P; Mazón MJ; Santos V; Moreno-Bueno G; Cano A; Portillo F
Sci Rep; 2017 Mar; 7():44988. PubMed ID: 28332555
[TBL] [Abstract] [Full Text] [Related]
14. Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in tcf3-HLF-positive leukemic cells.
Piao J; Takai S; Kamiya T; Inukai T; Sugita K; Ohyashiki K; Delia D; Masutani M; Mizutani S; Takagi M
Cancer Lett; 2017 Feb; 386():131-140. PubMed ID: 27894958
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptome analysis of human OXR1 depleted cells reveals its role in regulating the p53 signaling pathway.
Yang M; Lin X; Rowe A; Rognes T; Eide L; Bjørås M
Sci Rep; 2015 Nov; 5():17409. PubMed ID: 26616534
[TBL] [Abstract] [Full Text] [Related]
16. Inhibitor of differentiation 4 (ID4): From development to cancer.
Patel D; Morton DJ; Carey J; Havrda MC; Chaudhary J
Biochim Biophys Acta; 2015 Jan; 1855(1):92-103. PubMed ID: 25512197
[TBL] [Abstract] [Full Text] [Related]
17. Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt/β-catenin signaling.
Shy BR; Wu CI; Khramtsova GF; Zhang JY; Olopade OI; Goss KH; Merrill BJ
Cell Rep; 2013 Jul; 4(1):1-9. PubMed ID: 23810553
[TBL] [Abstract] [Full Text] [Related]
18. E47 and Id1 interplay in epithelial-mesenchymal transition.
Cubillo E; Diaz-Lopez A; Cuevas EP; Moreno-Bueno G; Peinado H; Montes A; Santos V; Portillo F; Cano A
PLoS One; 2013; 8(3):e59948. PubMed ID: 23555842
[TBL] [Abstract] [Full Text] [Related]
19. Control of breast cancer growth and initiation by the stem cell-associated transcription factor tcf3.
Slyper M; Shahar A; Bar-Ziv A; Granit RZ; Hamburger T; Maly B; Peretz T; Ben-Porath I
Cancer Res; 2012 Nov; 72(21):5613-24. PubMed ID: 23090119
[TBL] [Abstract] [Full Text] [Related]
20. Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel.
Sella T; Chodick G; Barchana M; Heymann AD; Porath A; Kokia E; Shalev V
Cancer Causes Control; 2011 Nov; 22(11):1513-20. PubMed ID: 21847538
[TBL] [Abstract] [Full Text] [Related]
[Next]
